{
    "eid": "2-s2.0-85133502562",
    "title": "Clinical recommendations to diagnose and monitor patients with transthyretin amyloid cardiomyopathy in Asia",
    "cover-date": "2022-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Cardiology and Cardiovascular Medicine",
            "@code": "2705",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "amyloidosis",
        "Asian patients",
        "diagnosis",
        "guidelines",
        "healthcare resources",
        "transthyretin amyloid cardiomyopathy"
    ],
    "authors": [
        "Weiqin Lin",
        "Pairoj Chattranukulchai",
        "Alex P.W. Lee",
        "Yen Hung Lin",
        "Wen Chung Yu",
        "Houng Bang Liew",
        "Abraham Oomman"
    ],
    "citedby-count": 0,
    "ref-count": 54,
    "ref-list": [
        "Cardiac amyloidosis: experience in a tertiary cardiac referral centre",
        "Diagnostic imaging of cardiac amyloidosis",
        "American Heart Association Heart Failure and Transplantation Committee of the Council on clinical cardiology cardiac amyloidosis: Evolving diagnosis and management: a scientific statement from the American Heart Association",
        "Updates in cardiac amyloidosis diagnosis and treatment",
        "Cardiac amyloidosis: overlooked, underappreciated, and treatable",
        "Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system",
        "A new staging system for cardiac transthyretin amyloidosis",
        "Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis",
        "Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases",
        "JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis",
        "A simple staging system using biomarkers for wild-type transthyretin amyloid cardiomyopathy in Japan",
        "Advocacy statements for the role of99mTc-pyrophosphate scintigraphy in the diagnosis of transthyretin cardiac amyloidosis: a report of the Taiwan Society of Cardiology and the Society of Nuclear Medicine of the Republic of China",
        "Echocardiographic and electrocardiographic presentations of patients with endomyocardial biopsy-proven cardiac amyloidosis",
        "A rare variant of transthyretin-related amyloidosis associated with exclusive cardiomyopathy in a Hong Kong Chinese patient",
        "Clinical and genetic profiles of hereditary transthyretin amyloidosis in Taiwan",
        "Cardiac amyloidosis: a case series from India",
        "Trends in the amyloidosis mortality rate in Japan: a nationwide observational study from 1998 to 2019",
        "Cardiac amyloidosis",
        "Systemic amyloidosis recognition, prognosis, and therapy: a systematic review",
        "Amyloidosis cardiomyopathy: update in the diagnosis and treatment of the most common types",
        "THAOS Investigators. Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)",
        "Cardiac manifestations and prognostic implications of hereditary transthyretin amyloidosis associated with transthyretin Ala97Ser",
        "Hereditary transthyretin amyloidosis - clinical and genetic characteristics of a multiracial South-East Asian cohort in Singapore",
        "Hereditary transthyretin amyloidosis in multi-ethnic Malaysians",
        "Transthyretin amyloid cardiomyopathy associated with Ala81Val transthyretin mutation: A case report",
        "Concomitant transthyretin amyloidosis and severe aortic stenosis in elderly Indian population: A pilot study",
        "Transthyretin amyloidosis mimicking obstructive hypertrophic cardiomyopathy: A great imitator",
        "Case report regarding the evolution of electrocardiographic and echocardiographic features in cardiac amyloidosis",
        "Prevalence, incidence, and impact on mortality of conduction system disease in transthyretin cardiac amyloidosis",
        "Atrial fibrillation in transthyretin cardiac amyloidosis: predictors, prevalence, and efficacy of rhythm control strategies",
        "Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis",
        "Nonbiopsy diagnosis of cardiac transthyretin amyloidosis",
        "False-positive99mTechnetium-pyrophosphate scintigraphy in two patients with hypertrophic cardiomyopathy",
        "Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis",
        "Wild-type transthyretin amyloidosis in female patients - consideration of sex differences",
        "Phenotypic expressions of hereditary transthyretin Ala97Ser related amyloidosis (ATTR) in Taiwanese",
        "Characteristics of South Korean patients with hereditary transthyretin amyloidosis",
        "Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis",
        "Screening for transthyretin amyloid cardiomyopathy in everyday practice",
        "Cardiac amyloidosis-a review of current literature for the practicing physician",
        "CMR-based differentiation of AL and ATTR cardiac amyloidosis",
        "Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis",
        "How to image cardiac amyloidosis: a practical approach",
        "Utility of cardiac magnetic resonance imaging in the diagnosis, prognosis, and treatment of infiltrative cardiomyopathies",
        "Combination of commonly examined parameters is a useful predictor of positive99 mTc-labeled pyrophosphate scintigraphy findings in elderly patients with suspected transthyretin cardiac amyloidosis",
        "Validation of the Kumamoto criteria for prediction of99mtechnetium pyrophosphate scintigraphy positivity as a strategy for diagnosis of transthyretin cardiac amyloidosis: a retrospective cohort study in Kochi",
        "The importance of multimodality imaging in the diagnosis and management of patients with infiltrative cardiomyopathies: An update",
        "Advocacy statements for the role of99mTc-pyrophosphate scintigraphy in the diagnosis of transthyretin cardiac amyloidosis: A report of the Taiwan Society of Cardiology and the Society of Nuclear Medicine of the Republic of China",
        "Monitoring of asymptomatic family members at risk of hereditary transthyretin amyloidosis for early intervention with disease-modifying therapies",
        "Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy",
        "The evolving role of cardiovascular magnetic resonance imaging in the evaluation of systemic amyloidosis",
        "Native T1 and extracellular volume in transthyretin amyloidosis",
        "Diffusion tensor cardiovascular magnetic resonance in cardiac amyloidosis",
        "Rationale for a Singapore transthyretin amyloidosis registry"
    ],
    "affiliation": [
        {
            "affiliation-city": "Singapore City",
            "@id": "60106366",
            "affilname": "National University Health System",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60106366",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60073385",
            "affilname": "National Taiwan University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60069716",
            "affilname": "National Yang-Ming University Taiwan",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069716",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60026680",
            "affilname": "NUS Yong Loo Lin School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026680",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": null,
            "@id": "60024787",
            "affilname": "Prince of Wales Hospital Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024787",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60013314",
            "affilname": "Veterans General Hospital-Taipei",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013314",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Chennai",
            "@id": "60004534",
            "affilname": "Apollo Hospitals Group",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004534",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kota Kinabalu",
            "@id": "113213650",
            "affilname": "Hospital Queen Elizabeth II",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/113213650",
            "affiliation-country": "Malaysia"
        }
    ],
    "funding": [
        "MIMS",
        "Abbott",
        "Pfizer",
        "AstraZeneca",
        "Bayer",
        "Johnson & Johnson",
        "Novartis",
        "Sanofi",
        "Medtronic",
        "MSD",
        "Boehringer Ingelheim",
        "Boston Scientific"
    ]
}